5-year follow-up after primary percutaneous coronary intervention with a paclitaxel-eluting stent versus a bare-metal stent in acute ST-segment elevation myocardial infarction: a follow-up study of the PASSION (Paclitaxel-Eluting Versus Conventional Stent in Myocardial Infarction with ST-Segment Ele
Explore this paper's citation graph
Summary
No significant difference in major adverse cardiac events was observed in PES compared with BMS in primary percutaneous coronary intervention for STEMI, and no difference in the incidence of definite or probable ST was seen, although very late ST was almost exclusively seen after the use of PES.
- Type
- article
- Published
- 2011-01-01
- Cited by
- 130
- References
- 25
- OpenAlex
- https://openalex.org/W39529948
- Semantic Scholar
- https://api.semanticscholar.org/CorpusID:40428871
Keywords
Medicine, Myocardial infarction, Percutaneous coronary intervention, Internal medicine, Cardiology
References
- Maintenance of long-term clinical benefit with sirolimus-eluting stents in patients with ST-segment elevation myocardial infarction 3-year results of the SESAMI (sirolimus-eluting stent versus bare-metal stent in acute myocardial infarction) trial.
- The clinical impact of routine angiographic follow-up in randomized trials of drug-eluting stents: a critical assessment of "oculostenotic" reintervention in patients with intermediate lesions.
- Late clinical events after clopidogrel discontinuation may limit the benefit of drug-eluting stents: an observational study of drug-eluting versus bare-metal stents.
- 2009 Focused Updates: ACC/AHA Guidelines for the Management of Patients With ST‐Elevation Myocardial Infarction (Updating the 2004 Guideline and 2007 Focused Update) and ACC/AHA/SCAI Guidelines on Percutaneous Coronary Intervention (Updating the 2005 Guideline and 2007 Focused Update)
- The risk of stent thrombosis in patients with acute coronary syndromes treated with bare-metal and drug-eluting stents.
- A polymer-based, paclitaxel-eluting stent in patients with coronary artery disease.
- Sirolimus-eluting versus uncoated stents in acute myocardial infarction.
- Safety and efficacy of sirolimus- and paclitaxel-eluting coronary stents.
- Everolimus-eluting versus paclitaxel-eluting stents in coronary artery disease.
- Delayed Arterial Healing and Increased Late Stent Thrombosis at Culprit Sites After Drug-Eluting Stent Placement for Acute Myocardial Infarction Patients: An Autopsy Study
- Randomized trial of Sirolimus-Eluting Stent Versus Bare-Metal Stent in Acute Myocardial Infarction (SESAMI).
- Efficacy and safety of drug-eluting stents in ST-segment elevation myocardial infarction: a meta-analysis of randomized trials.
- Stent thrombosis up to 3 years after stenting for ST-segment elevation myocardial infarction versus for stable angina--comparison of the effects of drug-eluting versus bare-metal stents.
- Paclitaxel-eluting versus uncoated stents in primary percutaneous coronary intervention.
- Clinical End Points in Coronary Stent Trials: A Case for Standardized Definitions
- Cardiac structures track during the first 2 years of life and are associated with fetal growth and hemodynamics: the Generation R Study.
- Coronary stenting versus balloon angioplasty for acute myocardial infarction: a meta-regression analysis of randomized trials.
- Paclitaxel-eluting stents versus bare-metal stents in acute myocardial infarction.
- Management of acute myocardial infarction in patients presenting with persistent ST-segment elevation: the Task Force on the Management of ST-Segment Elevation Acute Myocardial Infarction of the European Society of Cardiology.
- Second-generation everolimus-eluting and paclitaxel-eluting stents in real-life practice (COMPARE): a randomised trial.
Cited by
- Resultados a largo plazo del stent farmacoactivo de zotarolimus según sus indicaciones de uso (aprobadas versus no aprobadas)
- Long-term Outcomes of Drug-eluting versus Bare-metal stent for ST-elevation Myocardial Infarction
- Drug-Eluting Stents versus Bare-Metal Stents in Taiwanese Patients with Acute Coronary Syndrome: An Outcome Report of a Multicenter Registry.
- Long-term Clinical and Angiographic Outcomes after Primary Stenting for ST Segment Elevation Myocardial Infarction Using a Paclitaxel-Eluting Stent: A Propensity Score-Matched Comparison with Bare-Metal Stents (Original)
- Drug-eluting stents versus bare metal stents in ST elevation myocardial infarction at a follow-up of three years or longer: A meta-analysis of randomized trials.
- Bare Metal Stents Versus Drug Eluting Stents: Where Do We Stand in 2015?
- First results of the DEB-AMI (drug eluting balloon in acute ST-segment elevation myocardial infarction) trial: a multicenter randomized comparison of drug-eluting balloon plus bare-metal stent versus bare-metal stent versus drug-eluting stent in primary percutaneous coronary intervention with 6-mont
- Very Late Hazard with Stenting versus Balloon Angioplasty for ST-Elevation Myocardial Infarction: A 16-Year Single-Center Experience
- Long-term safety and effectiveness of drug-eluting stents compared to bare metal stents in ST elevation myocardial infarction: findings from the Guthrie Health Off-label Stent (GHOST) Registry.
- Long-term outcome of drug-eluting vs. bare-metal stents in patients with acute myocardial infarction. Subgroup analysis of the nagoya acute myocardial infarction study (NAMIS).
- New generation drug‐eluting stents for ST‐elevation myocardial infarction: A new paradigm for safety
- Controversies in the use & implementation of drug-eluting stent technology
- Stent thrombosis in new-generation drug-eluting stents in patients with STEMI undergoing primary PCI: a report from SCAAR.
- Safety and outcome of coronary interventions with special reference to anticoagulation and stent type
- Chinese Herbal Medicines Might Improve the Long-Term Clinical Outcomes in Patients with Acute Coronary Syndrome after Percutaneous Coronary Intervention: Results of a Decision-Analytic Markov Model
- REVascularization with paclitaxEL‐coated balloon angioplasty versus drug‐eluting stenting in acute myocardial infarcTION—A randomized controlled trial: Rationale and design of the REVELATION trial
- Drug-eluting stents during ST-segment elevation acute myocardial infarction: a critical analysis.
- Drug-eluting stents compared to bare-metal stents improve short-term survival in patients with acute myocardial infarction undergoing primary percutaneous coronary intervention: a nationwide prospective analysis of the AMIS Plus registry.
- Meta-analysis of long-term outcomes for drug-eluting stents versus bare-metal stents in primary percutaneous coronary interventions for ST-segment elevation myocardial infarction.
- A Case of Stent Thrombosis Occurred at 5 Years after Sirolimus-Eluting Stent Implantation
Related papers
- AS-144: Impact of Age on the Percutaneous Coronary Intervention Outcomes in the Drug-Eluting Stent Era
- The Usefulness of C-Reactive Protein to Albumin Ratio in the Prediction of Adverse Cardiovascular Events in Coronary Chronic Total Occlusion Undergoing Percutaneous Coronary Intervention
- [Present circumstance around percutaneous coronary intervention (PCI): before and after drug eluting stent (DES) introduction].
- One year clinical outcomes in patients with chronic kidney disease treated by percutaneous coronary intervention with drug-eluting stent.
- TCT-31 Clinical Impact of Genetics on Clopidogrel-Based Antiplatelet Therapy After Percutaneous Coronary Intervention Using Drug-Eluting Stent
- Comparison of stent graft, sirolimus stent, and bare metal stent implanted in patients with acute coronary syndrome: clinical and angiographic follow-up.
- Long term outcomes in octogenarians undergoing percutaneous coronary intervention: comparison of bare metal versus drug eluting stent.
- AS-189: Incidence and Clinical Outcomes Associated with Stent Fracture in Contemporary Percutaneous Coronary Intervention with Drug-Eluting Stents
- Hemodynamic analysis of edge stenosis in peripheral artery stent grafts.